Insider trade

Marchex (MCHX): President received 400K units

Travis Fairchild, President at Marchex, reported a grant / award of 400K units.

400K
Derivative units
Traded
Nov 9, 2026
Filed
Nov 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Nov 10, 2026Company filing · Form 8-K · ResultsReported its results
    2. Nov 10, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On November 9, 2026, the Board of Directors of Marchex, Inc. (“Marchex” or the “Company”) appointed Travis Fairchild (“Fairchild”) President of Marchex. Fairchild, age 53, previously served as Chief Executive Officer ("CEO") of Archenia, Inc., which Marchex acquired in July 2026, and brings extensive experience in AI-powered customer engagement, strategic development, and enterprise technology solutions.”
    View the official recordSEC Form 4

    How to read SEC Form 4

    Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

    Full guide: What is an SEC Form 4?

    What else is on file for Marchex

    OQRO holds no insider, Congress, fund or contract record for Marchex dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCHX page.

    How this filing works

    Explore the data

    Other disclosures at Marchex

    Everything OQRO holds on this company is on its MCHX page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data